=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
THE EINSTEIN REPORT
"Experience Tomorrow's Winners TODAY"
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Company Profile
Rapid Bio Tests Corp
Symbol: RBIO
Exchange: OTC BB
Berlin Exchange Symbol: RPB or 812438
Current Price: 77c

Interview done on Monday - Jan 12th:

http://www.ceocast.com/company.cfm?cid=3D13653

A VERY SIGNIFICANT NEWS RELEASE WAS SENT OUT ON FRIDAY !!

An excerpt from the NEWS RELEASE:

"Rapid Bio Tests Corp further believes that it will be able to deve= lop a test,
to test for the presence of BSE that will be capable of testing =FFFFFF93live = animals
as well as humans=FFFFFF94 and will produce results in less than 30 minutes, w= ithout
the need for a laboratory setting or experienced technicians. The compan= y
further believes that it has identified ways of blocking infective prion=
transport to the brain, thereby preventing the development of the diseas= e in
both animals and humans."

Did you read that ?? Besides the TEST - which is big news in itsel= f these guys
think they have a way of TREATING Mad Cow or BSE in animals as well as <= br> humans !!!!

This stock will go absolutely CRAZY once people know whats going on here=

About Rapid Bio Tests Corporation - RBIO

Rapid Bio Tests Corporation is a diagnostics company, which has develope= d rapid
diagnostic testing technology platforms, that will be used for the= development
and manufacturing of an array of rapid diagnostic tests. These tests&nbs= p; will not
require instrumentation or electricity and will be simple to use in the = field
or office and will only require a few minutes to produce a result. The i= nitial
tests that the Corporation is proposing to develop include; West Nile Vi= rus,
Hepatitis B, HIV 1 and 2, Tuberculosis, Bubonic Plague and the four stra= ins of
Malaria.

The directors of RBIO all hold PhD degrees.

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

NEWS RELEASE:

Rapid Bio Tests Announces Mad Cow Test and Treatment

Source: Business Wire

Publication date: 2004-01-09

Rapid Bio Tests Corporation(RBIO), reports that it has been conducting feasibility
studies related to Bovine Spongiform Encephalopathy or Mad Cow Disease (= BSE). The
company has taken this initiative in response to the confirmation of a slaughtered
dairy cow, testing positive for the disease, on December 23, 2003 in Mab= ton,
Washington.

Rapid Bio Tests Corporation has determined that the level of testing presently conducted, in North America, to establish the presence of BSE = is
inadequate and that the present system of limited testing of slaughtered= animals
presents a risk of infected meat reaching the food chain because of it. = At present,
of the 37 million cattle slaughtered annually in the United States a sma= ll
percentage representing approximately 0.05 percent or 20,000, animals ar= e actually
tested. In contrast, European nations last year tested 19 million cattle= with
4200 cases of Mad Cow Disease detected. In Japan, every cow headed for t= he dinner
table is tested for the disease, which represented approximately 1.2 mil= lion cattle
last year. Present day testing in North America is slow, with the recent= case in
Mabton, Washington taking 13 days to complete.

The company's initiative is focused in two areas, that being it's abilit= y to
develop a rapid diagnostic test for the purpose of establishing the pres= ence of
Mad Cow Disease in "live" animals and in humans and secondly t= he company's ability
to develop an effective procedure to treat the disease or slow it down.

Rapid Bio Tests Corporation studies indicate that it has the capabilitie= s to
develop a rapid diagnostic test using its existing technology platforms,=
proprietary knowledge and present scientific research personnel. The com= pany
further believes that it will be able to develop a procedure to test for= the
presence of BSE in "live animals as well as humans," with resu= lts in less than
30 minutes without the need for a laboratory setting or experienced technicians.
The company further believes that it has identified ways of blocking inf= ective
prion transport to the brain, thereby preventing the development of the = disease
in both animals and humans.

Presently the company is continuing to conduct feasibility studies on bo= th of
these initiatives with the primary consideration being the company's abi= lity to
finance the research and development of the test and the treatment. Consideration
will be given to financing the projects internally or to jointly proceed= ing with
an industry partner if necessary. The company is presently conducting additional
scientific study to determine product viability and from there it will determine
if the necessary funding can be put in place to proceed.

End of news release.

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

DISCLAIMER:

All material herein was prepared by The Einstein Report (TER). The infor= mation
contained herein is not guaranteed by TER to be accurate, and should not= be
considered to be all-inclusive. The companies that are discussed in this= opinion
have not approved the statements made in this opinion. This opinion cont= ains
forward-l00king statements that involve risks and uncertainties. A compa= ny's
actual results could differ materially from those described in any forward-l00king
statements or announcements discussed herein. This material is for informational
purposes only and should not be construed as an offer or solicitation of= an offer
to buy or sell securities. TER is not a licensed broker, broker dealer, = market
maker, investment banker, investment advisor, analyst or underwriter. Pl= ease
consult a stock broker before purchasing or selling any securities menti= oned in
TER. TER mentions very high risk stocks. Purchasing these stocks can res= ult
in the partial loss or possibly full loss of funds. Investing in stocks = is risky,
especially in OTC Bulletin Board stocks. The principals of TER may hold = a
position in a stock that they are reporting on and may buy or sell at an= y time
without prior notice
If you want to remove from this list please send one email to remove@com= puserve.com